Testicular cancer

Clinical practice guidelines

Robert J. Motzer, Robert R. Bahnson, Barry Boston, Michael A Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, Gary R. Hudes, Philip Kantoff, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Chris Logothetis, Kim A. Margolin, Bruce G. Redman, Sylvia Richey, Cary N. Robertson, Wolfram E. Samlowski, Joel Sheinfeld, Donald A. Urban

Research output: Contribution to journalArticle

Abstract

Ninety five percent of malignant tumors arising in the testes are germ cell tumors (GCTs). Although GCTs are relatively uncommon tumors, comprising only 2% of all human malignancies, they constitute the most common solid tumor in men between 15 and 34. Additionally, the worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCT are cured, but a delay in diagnosis can correlate with a higher stage at presentation. Standard therapy has been developed for essentially all stages of management and must be closely followed to ensure the potential for cure.

Original languageEnglish (US)
Pages (from-to)52-76
Number of pages25
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume3
Issue number1
StatePublished - Jan 2005

Fingerprint

Testicular Neoplasms
Practice Guidelines
Germ Cell and Embryonal Neoplasms
Neoplasms
Testis
Incidence

Keywords

  • Alpha-fetoprotein
  • Cisplatin
  • Germ cell tumors
  • Human chorionic gonadotropin
  • Lactate dehydrogenase
  • NCCN Clinical Practice Guidelines
  • Nonseminoma
  • Seminoma
  • Testicular cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Motzer, R. J., Bahnson, R. R., Boston, B., Carducci, M. A., Fishman, M., Hancock, S. L., ... Urban, D. A. (2005). Testicular cancer: Clinical practice guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 3(1), 52-76.

Testicular cancer : Clinical practice guidelines. / Motzer, Robert J.; Bahnson, Robert R.; Boston, Barry; Carducci, Michael A; Fishman, Mayer; Hancock, Steven L.; Hauke, Ralph J.; Hudes, Gary R.; Kantoff, Philip; Kuzel, Timothy M.; Lange, Paul H.; Levine, Ellis G.; Logothetis, Chris; Margolin, Kim A.; Redman, Bruce G.; Richey, Sylvia; Robertson, Cary N.; Samlowski, Wolfram E.; Sheinfeld, Joel; Urban, Donald A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 3, No. 1, 01.2005, p. 52-76.

Research output: Contribution to journalArticle

Motzer, RJ, Bahnson, RR, Boston, B, Carducci, MA, Fishman, M, Hancock, SL, Hauke, RJ, Hudes, GR, Kantoff, P, Kuzel, TM, Lange, PH, Levine, EG, Logothetis, C, Margolin, KA, Redman, BG, Richey, S, Robertson, CN, Samlowski, WE, Sheinfeld, J & Urban, DA 2005, 'Testicular cancer: Clinical practice guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 3, no. 1, pp. 52-76.
Motzer RJ, Bahnson RR, Boston B, Carducci MA, Fishman M, Hancock SL et al. Testicular cancer: Clinical practice guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2005 Jan;3(1):52-76.
Motzer, Robert J. ; Bahnson, Robert R. ; Boston, Barry ; Carducci, Michael A ; Fishman, Mayer ; Hancock, Steven L. ; Hauke, Ralph J. ; Hudes, Gary R. ; Kantoff, Philip ; Kuzel, Timothy M. ; Lange, Paul H. ; Levine, Ellis G. ; Logothetis, Chris ; Margolin, Kim A. ; Redman, Bruce G. ; Richey, Sylvia ; Robertson, Cary N. ; Samlowski, Wolfram E. ; Sheinfeld, Joel ; Urban, Donald A. / Testicular cancer : Clinical practice guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2005 ; Vol. 3, No. 1. pp. 52-76.
@article{658fecf462dc4e49864aea23dd7c9fd1,
title = "Testicular cancer: Clinical practice guidelines",
abstract = "Ninety five percent of malignant tumors arising in the testes are germ cell tumors (GCTs). Although GCTs are relatively uncommon tumors, comprising only 2{\%} of all human malignancies, they constitute the most common solid tumor in men between 15 and 34. Additionally, the worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90{\%} of all patients diagnosed with GCT are cured, but a delay in diagnosis can correlate with a higher stage at presentation. Standard therapy has been developed for essentially all stages of management and must be closely followed to ensure the potential for cure.",
keywords = "Alpha-fetoprotein, Cisplatin, Germ cell tumors, Human chorionic gonadotropin, Lactate dehydrogenase, NCCN Clinical Practice Guidelines, Nonseminoma, Seminoma, Testicular cancer",
author = "Motzer, {Robert J.} and Bahnson, {Robert R.} and Barry Boston and Carducci, {Michael A} and Mayer Fishman and Hancock, {Steven L.} and Hauke, {Ralph J.} and Hudes, {Gary R.} and Philip Kantoff and Kuzel, {Timothy M.} and Lange, {Paul H.} and Levine, {Ellis G.} and Chris Logothetis and Margolin, {Kim A.} and Redman, {Bruce G.} and Sylvia Richey and Robertson, {Cary N.} and Samlowski, {Wolfram E.} and Joel Sheinfeld and Urban, {Donald A.}",
year = "2005",
month = "1",
language = "English (US)",
volume = "3",
pages = "52--76",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Testicular cancer

T2 - Clinical practice guidelines

AU - Motzer, Robert J.

AU - Bahnson, Robert R.

AU - Boston, Barry

AU - Carducci, Michael A

AU - Fishman, Mayer

AU - Hancock, Steven L.

AU - Hauke, Ralph J.

AU - Hudes, Gary R.

AU - Kantoff, Philip

AU - Kuzel, Timothy M.

AU - Lange, Paul H.

AU - Levine, Ellis G.

AU - Logothetis, Chris

AU - Margolin, Kim A.

AU - Redman, Bruce G.

AU - Richey, Sylvia

AU - Robertson, Cary N.

AU - Samlowski, Wolfram E.

AU - Sheinfeld, Joel

AU - Urban, Donald A.

PY - 2005/1

Y1 - 2005/1

N2 - Ninety five percent of malignant tumors arising in the testes are germ cell tumors (GCTs). Although GCTs are relatively uncommon tumors, comprising only 2% of all human malignancies, they constitute the most common solid tumor in men between 15 and 34. Additionally, the worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCT are cured, but a delay in diagnosis can correlate with a higher stage at presentation. Standard therapy has been developed for essentially all stages of management and must be closely followed to ensure the potential for cure.

AB - Ninety five percent of malignant tumors arising in the testes are germ cell tumors (GCTs). Although GCTs are relatively uncommon tumors, comprising only 2% of all human malignancies, they constitute the most common solid tumor in men between 15 and 34. Additionally, the worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCT are cured, but a delay in diagnosis can correlate with a higher stage at presentation. Standard therapy has been developed for essentially all stages of management and must be closely followed to ensure the potential for cure.

KW - Alpha-fetoprotein

KW - Cisplatin

KW - Germ cell tumors

KW - Human chorionic gonadotropin

KW - Lactate dehydrogenase

KW - NCCN Clinical Practice Guidelines

KW - Nonseminoma

KW - Seminoma

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=33747627379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747627379&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 52

EP - 76

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 1

ER -